SCHEMBL17820124

SCHEMBL17820124

CC(=O)c1ncc(CO)cn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
DYRK1A Q13627 1/20 0.33
KMT2A Q03164 2/20 0.32
CYP4F2 P78329 2/20 0.32
CYP4A11 Q02928 2/20 0.32
TSHR P16473 3/20 0.31
FYN P06241 2/20 0.31
CYP3A4 P08684 2/20 0.31
KDM4E B2RXH2 2/20 0.31
PKM P14618 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
NFKB1 P19838 1/20 0.31
THPO P40225 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24723878 0.82 NPC1 (0.40) ALDH1A1KMT2ATSHRCYP3A4KDM4E
SCHEMBL25406160 0.80 ALDH1A1 (0.37) ALDH1A1KMT2ATSHRCYP3A4KDM4E
SCHEMBL17819455 0.80 ALDH1A1 (0.33) ALDH1A1KMT2ATSHRCYP3A4KDM4E
SCHEMBL24786953 0.79 P4HTM (0.39) ALDH1A1KMT2ACYP4F2CYP4A11TSHR
SCHEMBL23021755 0.77 FAAH (0.35) ALDH1A1KMT2ACYP3A4KDM4EMEN1
SCHEMBL25406145 0.74 HSP90AB1 (0.47) ALDH1A1CYP4F2CYP4A11PKMLMNA
SCHEMBL882970 0.73 APLNR (0.50) ALDH1A1KDM4ECYP1A2MAPTTDP1
SCHEMBL14651299 0.72 P4HTM (0.47) ALDH1A1KMT2ACYP4F2CYP4A11TSHR
SCHEMBL10588266 0.72 L3MBTL1 (0.44) TSHRFYNKDM4EL3MBTL1LMNA
SCHEMBL17819676 0.71 HRH3 (0.48) ALDH1A1KMT2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023134629-A1 NUCLEAR TRANSPORT REGULATOR AND USE THEREOF 上海海雁医药科技有限公司 2023-07-20 WO disclosed
EP-3042900-B1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORP (JP) 2020-09-23 EP disclosed
US-9586951-B2 Morpholine derivative or salt thereof FUJIFILM CORPORATION (JP) 2017-03-07 US disclosed
US-9586951-B2 Morpholine derivative or salt thereof FUJIFILM CORPORATION (JP) 2017-03-07 US disclosed
US-9586951-B2 Morpholine derivative or salt thereof FUJIFILM CORPORATION (JP) 2017-03-07 US disclosed
EP-3042900-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF Fujifilm Corporation (JP) 2016-07-13 EP disclosed
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2016-06-16 US disclosed
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2016-06-16 US disclosed
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF PRMT7, RBBP7, RER1 ALDH1A1 2519/4885DYRK1A 3347/4885KMT2A 1128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.